Journal of Peking University(Health Sciences) ›› 2019, Vol. 51 ›› Issue (2): 293-297. doi: 10.19723/j.issn.1671-167X.2019.02.018

Previous Articles     Next Articles

Comparison of effectiveness and complications between two different methods of augmentation cystoplasty

Chen LIANG,Wei-yu ZHANG,Hao HU,Qi WANG,Zhi-wei FANG,Ke-xin XU()   

  1. Department of Urology, Peking University People’s Hospital, Beijing 100044, China
  • Received:2017-03-15 Online:2019-04-18 Published:2019-04-26
  • Contact: Ke-xin XU E-mail:cavinx@sina.com

RICH HTML

  

Abstract:

Objective: To compare the effectiveness and complications between enterocystoplasty and small intestinal submucosa (SIS) cystoplasty through follow-ups of patients with augmentation cystoplasty in Peking University People’s Hospital, offering alternative approach for future treatment.Methods: In this study, retrospective analyses were carried out in 10 patients who underwent enterocystoplasty or SIS cystoplasty in Peking University People’s Hospital from November 2011 to December 2016. Clinical data were collected including medical history, surgical procedures, laboratory examinations and complications. And then regular follow-ups were developed. Ten patients were separated into groups of enterocystoplasty (n=6) and SIS cystoplasty (n=4), to compare their outcomes.Results: Ten patients all completed the follow-up interview. Five cases underwent augmentation cystoplasty with sigmoid colon, one with ileum and four with SIS cystoplasty successfully. The mean operative time was (302.0±66.6) min, and blood loss was (167.0±135.0) mL. The outcomes of the group of SIS cystoplasty were better in respects of the time of operation, intestinal function recovery, postoperative hospitalization duration and drainage removal. The average scores of American Urological Association symptom score (AUASS), overactive bladder syndrome score (OABSS), International Consultation on Incontinence questionnaire short form (ICI-Q-SF), and O’Leary-Sant Questionnaire were all improved in two groups. Two cases carried clean intermittent self catheterazion and two used long-term indwelling catheter. There were three patients with dilations of renal pelvises and ureters consistently or during bladder was filling preoperatively, and the situations were not going bad after the operations. The short-term complications included two cases of postoperative infection, one case of mild intestinal obstruction and one case of metabolic acidosis. The long-term complications included one case of ureteroinstestinal anastomosis strictures, three of urinary tract infection and one of long-term metabolic acidosis.Conclusion: Enterocystoplasty and SIS cystoplasty are both effective operations to improve symptoms and protect upper urinary function, with no severe complications. Cystoscopic results showed satisfactory mucosa regeneration after SIS cystoplaty in refractory interstitial cystitis/painful bladder syndrome. But the number of patients included were quite small and the follow-up period was not long enough. Prospective control study of larger number of patients with longer follow-ups are expected to find out the effectiveness and safety of SIS cystoplasty.

Key words: Urinary bladder diseases, Biocompatible materials, Tissue engineering, Urologic surgical procedures, Postoperative complications

CLC Number: 

  • R699.5

Table 1

Intraoperative and postoperative situations of patients in enterocystoplasty group and SIS cystoplasty group"

Items Enterocystoplasty group SIS cystoplasty group P value
n 6 4
ASA classification, x?±s 1.8±0.4 1.7±0.5 0.779
Duration of operation/min, x?±s 318.0±21.4 170.0±14.1 <0.001
Intraoperative bleeding/mL, x?±s 216.7±147.2 92.5±78.9 0.165
Intestinal function recovery/d, x?±s 7.2±2.6 2.8±2.9 0.034
Postoperative hospitalization duration/d, x?±s 12.2±2.2 8.0±0.8 0.008
Removal of abdominal drainage postoperatively/d, x?±s 8.2±2.2
Removal of pelvic drainage postoperatively/d, x?±s 8.3±1.5 5.3±2.1 0.025
Removal of suprapubic catheter postoperatively/d, x?±s 24.2±20.5 0.132
Removal of urinary catheter postoperatively/d, x?±s 27.5±15.1 37.5±9.6 0.278

Table 2

The average score of AUASS, OABSS, ICI-Q-SF, and O’Leary-Sant in enterocystoplasty group and SIS cystoplasty group"

Items AUASS OABSS ICI-Q-SF O’Leary-Sant score
Enterocystoplasty (n=6)
Preoperative, x?±s 23.0±3.7 7.4±2.4 9.4±9.0
Postoperative, x?±s 8.4±6.1 2.6±5.8 2.2±2.0
P value 0.001 0.007 0.059
SIS cystoplasty (n=4)
Preoperative, x?±s 17.3±2.3 7.7±1.2 3.3±5.8 28.0±1.4
Postoperative, x?±s 7.6±4.7 3.0±1.7 0.7±1.2 7.0±0.0
P value 0.017 0.009 <0.001 0.001

Figure 1

Flocculent necrotic tissue was seen by cystoscope at the place of patch one month postoperatively (A), regenerative mucosa were smooth and the patch was absorbed completely by cystoscope seven months postoperatively (B)"

[1] Biers SM, Venn SN, Greenwell TJ . The past, present and future of augmentation cystoplasty[J]. BJU Int, 2012,109(9):1280-1293.
doi: 10.1111/bju.2012.109.issue-9
[2] Drake M, Apostolidis A, Emmanuel A , et al. Neurologicalurinary and faecal incontinence[M]. Paris: ICUD-EAU, 2013: 827-954.
[3] Groen J, Pannek J, Castro DD , et al. Summary of European Association of Urology (EAU)guidelines on neurourology[J]. Eur Urol, 2016,69(2):324-333.
doi: 10.1016/j.eururo.2015.07.071
[4] Stohrer M, Goepel M, Kondo A , et al. The standardization of terminology in neurogenic lower urinary tract dysfunction: with suggestions for diagnostic procedures. International Continence Society Standardization Committee[J]. Neurourol Urodyn, 1999,18(2):139-158.
doi: 10.1002/(ISSN)1520-6777
[5] Manack A, Motsko SP, Haag-Molkenteller C , et al. Epidemiology and healthcare utilization of neurogenic bladder patients in a US claims database[J]. Neurourol Urodyn, 2011,30(3):395-401.
doi: 10.1002/nau.v30.3
[6] European Association Of Urology. Guidelines on neurogenic low urinary tract dysfunction (2012) [EB/OL]. [ 2016- 09- 25] .
[7] Consortium for Spinal Cord Medicine. Bladder management for adults with spinal cord injury: a clinical practice guideline for health-care providers[J]. J Spinal Cord Med, 2006,29(5):527-573.
[8] Abrams P, Cardozo L, Fall M , et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society[J]. Am J Obstet Gynecol, 2002,187(1):116-126.
doi: 10.1067/mob.2002.125704
[9] Davis NF, Brady CM, Creagh T . Interstitial cystitis/painful bladder syndrome: epidemiology, pathophysiology and evidence-based treatment options[J]. Eur J Obstet Gynecol Reprod Biol, 2014,175:30-37.
doi: 10.1016/j.ejogrb.2013.12.041
[10] Dahms SE, Piechota HJ, Dahiya R , et al. Composition and biomechanical properties of the bladder acellular matrix graft: comparative analysis in rat, pig and human[J]. Br J Urol, 1998,82(3):411-419.
doi: 10.1046/j.1464-410X.1998.00748.x
[11] Kropp BP . Small-intestinal submucosa for bladder augmentation: a review of preclinical studies[J]. World J Urol, 1998,16(4):262-267.
doi: 10.1007/s003450050064
[12] Kropp BP, Sawyer BD, Shannon HE , et al. Characterization of small intestinal submucosa regenerated canine detrusor: assessment of reinnervation, in vitro compliance and contractility[J]. J Urol, 1996,156(2 Pt 2):599-607.
doi: 10.1016/S0022-5347(01)65761-6
[13] Kropp BP, Cheng EY, Lin HK , et al. Reliable and reproducible bladder regeneration using unseeded distal small intestinal submucosa[J]. J Urol, 2004,172(4 Pt 2):1710-1713.
doi: 10.1097/01.ju.0000139952.64753.27
[14] Kropp BP, Cheng EY . Bioengineering organs using small intestinal submucosa scaffolds: in vivo tissue-engineering technology[J]. J Endourol, 2000,14(1):59-62.
doi: 10.1089/end.2000.14.59
[15] Liao L, Zhang F, Chen G . Midterm outcomes of protection for upper urinary tract function by augmentation enterocystoplasty in patients with neurogenic bladder[J]. Int Urol Nephrol, 2014,46(11):2117-2125.
doi: 10.1007/s11255-014-0782-2
[16] Lam Van Ba O, Aharony S, Loutochin O , et al. Bladder tissue engineering: a literature review[J]. Adv Drug Deliv Rev, 2015, 82-83:31-37.
doi: 10.1016/j.addr.2014.11.013
[1] Mingrui WANG,Jun LIU,Liulin XIONG,Luping YU,Hao HU,Kexin XU,Tao XU. Efficacy and safety of mini-track, mini-nephroscopy and mini-ultrasonic probe percutaneous nephrolithotomy for the treatment of 1.5-2.5 cm kidney stones [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 605-609.
[2] Xiaoying CHEN,Yi ZHANG,Yuke LI,Lin TANG,Yuhua LIU. Effects of different polymers on biomimetic mineralization of small intestine submucosal scaffolds [J]. Journal of Peking University (Health Sciences), 2024, 56(1): 17-24.
[3] Su-huan XU,Bei-bei WANG,Qiu-ying PANG,Li-jun ZHONG,Yan-ming DING,Yan-bo HUANG,Xin-yan CHE. Effect of equal temperature bladder irrigation in patients with transurethral resection of prostate: A meta-analysis [J]. Journal of Peking University (Health Sciences), 2023, 55(4): 676-683.
[4] Yu-ke LI,Mei WANG,Lin TANG,Yu-hua LIU,Xiao-ying CHEN. Effect of pH on the chelation between strontium ions and decellularized small intestinal submucosal sponge scaffolds [J]. Journal of Peking University (Health Sciences), 2023, 55(1): 44-51.
[5] Hui LI,Yang-xu GAO,Shu-lei WANG,Hong-xin YAO. Surgical complications of totally implantable venous access port in children with malignant tumors [J]. Journal of Peking University (Health Sciences), 2022, 54(6): 1167-1171.
[6] LI Wei-hao,LI Wei,ZHANG Xue-min,LI Qing-le,JIAO Yang,ZHANG Tao,JIANG Jing-jun,ZHANG Xiao-ming. Comparison of the outcomes between open and hybrid approaches in the treatment of thoracoabdominal aortic aneurysms repair [J]. Journal of Peking University (Health Sciences), 2022, 54(1): 177-181.
[7] HUANG Li-dong,GONG Wei-yu,DONG Yan-mei. Effects of bioactive glass on proliferation, differentiation and angiogenesis of human umbilical vein endothelial cells [J]. Journal of Peking University (Health Sciences), 2021, 53(2): 371-377.
[8] Mei WANG, Bo-wen LI, Si-wen WANG, Yu-hua LIU. Preparation and osteogenic effect study of small intestinal submucosa sponge [J]. Journal of Peking University (Health Sciences), 2020, 52(5): 952-958.
[9] Wen-min DONG,Ming-rui WANG,Hao HU,Qi WANG,Ke-xin XU,Tao XU. Initial clinical experience and follow-up outcomes of treatment for ureteroileal anastomotic stricture with Allium coated metal ureteral stent [J]. Journal of Peking University (Health Sciences), 2020, 52(4): 637-641.
[10] Jian GAO,Li-bao HU,Chen CHEN,Xin ZHI,Tao XU. Interventional treatment of hemorrhage after percutaneous nephrolithotomy [J]. Journal of Peking University (Health Sciences), 2020, 52(4): 667-671.
[11] Wei-yi WU,Bo-wen LI,Yu-hua LIU,Xin-zhi WANG. Biodegradation properties of multi-laminated small intestinal submucosa [J]. Journal of Peking University (Health Sciences), 2020, 52(3): 564-569.
[12] Kai MA,Xing-ke QU,Qing-quan XU,Liu-lin XIONG,Xiong-jun YE,Li-zhe AN,Wei-nan CHEN,Xiao-bo HUANG. Endoscopic treatment for ureterovesical junction stenosis in patients with kidney transplantation: 13 cases report [J]. Journal of Peking University(Health Sciences), 2019, 51(6): 1155-1158.
[13] Rong LI,Ke-long CHEN,Yong WANG,Yun-song LIU,Yong-sheng ZHOU,Yu-chun SUN. Establishment of a 3D printing system for bone tissue engineering scaffold fabrication and the evaluation of its controllability over macro and micro structure precision [J]. Journal of Peking University(Health Sciences), 2019, 51(1): 115-119.
[14] Jia-xuan XU,Hong-zhi WANG,Jun DONG,Xiao-jie CHEN,Yong YANG,Ren-xiong CHEN,Guo-dong WANG. Analysis of risk factors for acute lung injury/acute respiratory distress syndrome after esophagectomy [J]. Journal of Peking University(Health Sciences), 2018, 50(6): 1057-1062.
[15] WANG Zi-cheng, CHENG Li, LV Tong-de, SU Li, LIN Jian, ZHOU Li-qun. Inflammatory priming adipose derived stem cells significantly inhibit the proliferation of peripheral blood mononuclear cells [J]. Journal of Peking University(Health Sciences), 2018, 50(4): 590-594.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!